UK's Cameron launches world's biggest dementia study

June 19, 2014

The world's largest study of dementia was launched by British Prime Minister David Cameron on Thursday as part of a drive to speed up the search for treatments.

"The truth is that dementia now stands alongside cancer as one of the greatest enemies of humanity," Cameron told a London summit on dementia, a range of conditions causing that affect 40 million people globally.

The new study will collect the medical and lifestyle data of two million volunteers in Britain aged over 50, using cognitive studies, brain imaging and genetics to shed light on causes and possible treatments for dementia, the most common form of which is Alzheimer's disease.

The information collected is expected to help scientists identify those most at risk of developing dementia and pinpoint causes and risk factors for disease.

"We need to join up the dots and create a big, bold global push to beat this," Cameron said, saying that regulations should be eased to allow new drugs to be tested earlier.

"It will take years of work but we have shown with other diseases that we can make progress and we will do so again."

Cameron criticised a "market failure" that meant global spending on dementia was five times smaller than investment into , meaning only three drugs had been released to market in 15 years.

He called on governments to create incentives for research into dementia, which cost the global economy $604 billion in 2010, according to Alzheimer's Disease International.

Britain used its 2013 presidency of the G8 to call an international summit on dementia, at which experts set a goal to find a cure by 2025.

The British government is to put forward proposals to extend the length that drug companies can hold patents to incentivise research, and is increasing its funding for research to £66 million ($113 million, 82 million euros) in 2015, up from £28 million in 2009.

The event also launched a £100 million project by the Alzheimer's Research UK campaign, which includes opening a stem cell research centre and a network of drug research units in universities.

Explore further: UK says cure or drug for dementia possible by 2025

Related Stories

UK says cure or drug for dementia possible by 2025

December 11, 2013
British Prime Minister David Cameron says he hopes to kick-start an international effort to find a cure or effective treatment for dementia by 2025.

G8 sets 2025 dementia breakthrough target (Update)

December 11, 2013
Finding a cure or treatment for dementia by 2025 is within reach, British Prime Minister David Cameron said Wednesday at the first-ever G8 meeting on combating the disease.

Dementia cases to treble worldwide by 2050 (Update)

December 5, 2013
The number of people suffering from dementia worldwide is set to explode in the coming decades as the population ages, trebling by 2050, according to a study released Thursday.

Need for dementia caregivers grows as boomers age

December 17, 2013
World leaders set a goal for a cure or treatment for dementia by 2025 at the recent G8 summit in London.

A new diagnostic tool for dementia diseases

June 5, 2014
A new diagnostic tool helps clinicians to differentiate between Alzheimer's disease, frontotemporal dementia and mild cognitive impairment. Presented in the doctoral thesis of MD Miguel Ángel Muñoz Ruiz at the University ...

Depression in the elderly linked to Alzheimer's risk

June 9, 2014
Many people develop depression in the latest stages of life, but until now doctors had no idea that it could point to a build up of a naturally occurring protein in the brain called beta-amyloid, a hallmark of Alzheimer's ...

Recommended for you

Alzheimer's disease: Neuronal loss very limited

January 17, 2018
Frequently encountered in the elderly, Alzheimer's is considered a neurodegenerative disease, which means that it is accompanied by a significant, progressive loss of neurons and their nerve endings, or synapses. A joint ...

Anxiety: An early indicator of Alzheimer's disease?

January 12, 2018
A new study suggests an association between elevated amyloid beta levels and the worsening of anxiety symptoms. The findings support the hypothesis that neuropsychiatric symptoms could represent the early manifestation of ...

One of the most promising drugs for Alzheimer's disease fails in clinical trials

January 11, 2018
To the roughly 400 clinical trials that have tested some experimental treatment for Alzheimer's disease and come up short, we can now add three more.

Different disease types associated with distinct amyloid-beta prion strains found in Alzheimer's patients

January 9, 2018
An international team of researchers has found different disease type associations with distinct amyloid-beta prion strains in the brains of dead Alzheimer's patients. In their paper published in Proceedings of the National ...

Advances in brain imaging settle debate over spread of key protein in Alzheimer's

January 5, 2018
Recent advances in brain imaging have enabled scientists to show for the first time that a key protein which causes nerve cell death spreads throughout the brain in Alzheimer's disease - and hence that blocking its spread ...

Molecular mechanism behind HIV-associated dementia revealed

January 5, 2018
For the first time, scientists have identified and inhibited a molecular process that can lead to neurodegeneration in patients with HIV, according to a Northwestern Medicine study published in Nature Communications.


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.